Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy
Jifa Zhang(Sichuan University), Liang Ouyang(Sichuan University)
Cited by 39
Related Papers
DYRK1A inhibitors for disease therapy: Current status and perspectives
|European Journal of Medicinal Chemistry|2021|103
Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy
|Chemical Communications|2021|85
Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
|Acta Pharmaceutica Sinica B|2022|83